Professional Media briefs: February 2013

Time Inc. has rebranded its targeted marketing division as ­Targeted Media Health and refocused it exclusively on pharma and other healthcare advertisers. The division also offers OTC and wellness-brand related content. “Adding targeted digital and mobile offerings, as well as an in-home magazine component, makes Targeted Media Health a one-stop solution for fulfilling the dimensional elements of any pharmaceutical brand initiative,” said VP managing director John Kenyon.

Wiley, the Physiological Society and the American Physiological Society have teamed up to create the open-access journal Physiological Reports. It is the first online-only journal for the societies and pools the peer-reviewed print and online research published in journals including ­Experimental Physiology.

Wolters Kluwer Health is now the owner of Health Language. The publisher wrapped the acquisition January 4. Health Language is a leader in medical management terminology, and its databases and software help groups like payers and hospitals reconcile medical vocabularies and administrative codes. Terms of the transaction were not disclosed.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.